Insuget 70/30 SpecificationRequires Prescription (YES/NO)YesGenericsHuman Insulin + Isophane insulinUsed ForDiabetes ManagementHow it worksThe major effects of insulin on carbohydrate homoeostasis following its binding to specific cell-surface receptors on insulin-sensitive tissues, notably the liver, muscles and adipose tissue. It inhibits hepatic glucose production and enhances peripheral glucose disposal thereby reducing blood-glucose concentration. It also inhibits lipolysis thereby preventing the formation of ketone bodies.Insuget 70/30 Usage And SafetyDosageHuman Insulin + Isophane insulinSide EffectsHypoglycemia : They may include cold sweat, cool pale skin, nervousness or tremor, anxious feeling, unusual tiredness or weakness, confusion, difficulty in concentration, headache, nausea and palpitation. Severe hypoglycemia may lead to unconsciousness and may result in temporary or permanent impairment of brain function or even death , Weight gain , Oedema and refraction anomalies , . Local hypersensitivity reactions (redness, swelling and itching at the injection site) , Lipodystrophy , generalised skin rash, itching, sweating, gastrointestinal upset, angioneurotic oedema, difficulties in breathing, palpitation and reduction in blood pressure.Drug InteractionsBeta blocking agent Oral hypoglycemic agents (OHA), octreotide, monoamine oxidase inhibitor (MAOI), non selective beta blocking agents, angiotensin converting enzyme (ACE) inhibitors, salicylates, alcohol and alcohol steroids , Oral contraceptives, thiazides, glucocorticoids, thyroid hormones and sympathomimetics, danazol etc.IndicationIt is indicated for the treatment of : Patients with Type I diabetes mellitus. - Patients with Type II diabetes mellitus either alone or in combination with oral anti-diabetic agents. - Patients with gestational diabetes. - The emergency management of diabetic ketoacidosis.When not to UseInsulin is contraindicated in: - Patients with hypersensitivity to any components of this medication. - Patients with hypoglycemia. - Patients in coma due to hyperglycemia.Insuget 70/30 PrecautionsPrecautionCare is also necessary during excessive exercise. Hypoglycemia caused by metabolic effects and increased insulin absorption is the usual response, but hyperglycemia may sometimes occur. Adjustment of insulin dosage may also be necessary if patients change their level of physical activity or change their usual diet.Insuget 70/30 WarningsWarning 1Insulin requirements may be increased during illness or emotional disturbances.Warning 2The use of insulin necessitates monitoring of therapy, such as the testing of blood or urine for glucose concentrations and the urine for ketones, by the patient .Warning 3Local reactions, characterised hypersensitivity may produce urticaria, angioedema and very rarely anaphylactic reactions. If continued therapy with insulin is essential, hyposensitisation procedures may need to be performed.Insuget 70/30 Additional InformationPregnancy categoryAlways consult your physician before using any medicine.Storage (YES/NO)Store in a refrigerator (2?C?8?C). Do not Freeze .
Insulatard is human insulin to treat diabetes.
?Insulatard is a long-acting insulin.
?Insulatard will start to lower your blood sugar about 1? hours after you take it, and the effect will last for approximately 24 ?hours. ?
?Insulatard is often given in combination with fast-acting insulin products.
Insulatard? vials are for use with insulin syringes with the corresponding unit scale.
Insulatard? is human insulin with a gradual onset and long duration of action.
Insulatard? is used to?reduce the high blood sugar level?in patients with diabetes mellitus (diabetes).
Insulatard? will start to lower your blood sugar about 1? hours after you inject it, and the effect will last for approximately 24 hours.
Insulatard? is often given in combination with fast-acting insulin preparations.
Treatment with Insulatard? helps to prevent complications from your diabetes.
Insulatard?FlexPen is a unique dial-a-dose insulin pen. You can select doses from 1 to 60 units in increments of 1 unit.
Insulatard?FlexPen is designed and tested to be used with NovoFine and NovoTwist disposable needles up to a length of 8 mm.?
Insulatard is a long-acting insulin.?
Insulatard will start to lower your blood sugar about 1? hours after you take it, and the effect will last for approximately 24 hours.
Insulatard is often given in combination with fast-acting insulin products.
Insulatard Hm SpecificationRequires Prescription (YES/NO)YesGenericsHuman InsulinUsed ForDiabetes ManagementHow it worksThe major effects of insulin on carbohydrate homoeostasis following its binding to specific cell-surface receptors on insulin-sensitive tissues, notably the liver, muscles and adipose tissue. It inhibits hepatic glucose production and enhances peripheral glucose disposal thereby reducing blood-glucose concentration. It also inhibits lipolysis thereby preventing the formation of ketone bodies.Insulatard Hm Usage And SafetyDosageHuman InsulinSide EffectsHypoglycemia : They may include cold sweat, cool pale skin, nervousness or tremor, anxious feeling, unusual tiredness or weakness, confusion, difficulty in concentration, headache, nausea and palpitation. Severe hypoglycemia may lead to unconsciousness and may result in temporary or permanent impairment of brain function or even death , Weight gain , Oedema and refraction anomalies , . Local hypersensitivity reactions (redness, swelling and itching at the injection site) , Lipodystrophy , generalised skin rash, itching, sweating, gastrointestinal upset, angioneurotic oedema, difficulties in breathing, palpitation and reduction in blood pressure.Drug InteractionsBeta blocking agent Oral hypoglycemic agents (OHA), octreotide, monoamine oxidase inhibitor (MAOI), non selective beta blocking agents, angiotensin converting enzyme (ACE) inhibitors, salicylates, alcohol and alcohol steroids , Oral contraceptives, thiazides, glucocorticoids, thyroid hormones and sympathomimetics, danazol etc.IndicationIt is indicated for the treatment of : Patients with Type I diabetes mellitus. - Patients with Type II diabetes mellitus either alone or in combination with oral anti-diabetic agents. - Patients with gestational diabetes. - The emergency management of diabetic ketoacidosis.When not to UseInsulin is contraindicated in: - Patients with hypersensitivity to any components of this medication. - Patients with hypoglycemia. - Patients in coma due to hyperglycemia.Insulatard Hm PrecautionsPrecautionCare is also necessary during excessive exercise. Hypoglycemia caused by metabolic effects and increased insulin absorption is the usual response, but hyperglycemia may sometimes occur. Adjustment of insulin dosage may also be necessary if patients change their level of physical activity or change their usual diet.Insulatard Hm WarningsWarning 1Insulin requirements may be increased during illness or emotional disturbances.Warning 2The use of insulin necessitates monitoring of therapy, such as the testing of blood or urine for glucose concentrations and the urine for ketones, by the patient .Warning 3Local reactions, characterised hypersensitivity may produce urticaria, angioedema and very rarely anaphylactic reactions. If continued therapy with insulin is essential, hyposensitisation procedures may need to be performed.Insulatard Hm Additional InformationPregnancy categoryAlways consult your physician before using any medicine.Storage (YES/NO)Store in a refrigerator (2?C?8?C). Do not Freeze .
Insulatard Hm SpecificationRequires Prescription (YES/NO)YesGenericsHuman InsulinUsed ForDiabetes ManagementHow it worksThe major effects of insulin on carbohydrate homoeostasis following its binding to specific cell-surface receptors on insulin-sensitive tissues, notably the liver, muscles and adipose tissue. It inhibits hepatic glucose production and enhances peripheral glucose disposal thereby reducing blood-glucose concentration. It also inhibits lipolysis thereby preventing the formation of ketone bodies.Insulatard Hm Usage And SafetyDosageHuman InsulinSide EffectsHypoglycemia : They may include cold sweat, cool pale skin, nervousness or tremor, anxious feeling, unusual tiredness or weakness, confusion, difficulty in concentration, headache, nausea and palpitation. Severe hypoglycemia may lead to unconsciousness and may result in temporary or permanent impairment of brain function or even death , Weight gain , Oedema and refraction anomalies , . Local hypersensitivity reactions (redness, swelling and itching at the injection site) , Lipodystrophy , generalised skin rash, itching, sweating, gastrointestinal upset, angioneurotic oedema, difficulties in breathing, palpitation and reduction in blood pressure.Drug InteractionsBeta blocking agent Oral hypoglycemic agents (OHA), octreotide, monoamine oxidase inhibitor (MAOI), non selective beta blocking agents, angiotensin converting enzyme (ACE) inhibitors, salicylates, alcohol and alcohol steroids , Oral contraceptives, thiazides, glucocorticoids, thyroid hormones and sympathomimetics, danazol etc.IndicationIt is indicated for the treatment of : Patients with Type I diabetes mellitus. - Patients with Type II diabetes mellitus either alone or in combination with oral anti-diabetic agents. - Patients with gestational diabetes. - The emergency management of diabetic ketoacidosis.When not to UseInsulin is contraindicated in: - Patients with hypersensitivity to any components of this medication. - Patients with hypoglycemia. - Patients in coma due to hyperglycemia.Insulatard Hm PrecautionsPrecautionCare is also necessary during excessive exercise. Hypoglycemia caused by metabolic effects and increased insulin absorption is the usual response, but hyperglycemia may sometimes occur. Adjustment of insulin dosage may also be necessary if patients change their level of physical activity or change their usual diet.Insulatard Hm WarningsWarning 1Insulin requirements may be increased during illness or emotional disturbances.Warning 2The use of insulin necessitates monitoring of therapy, such as the testing of blood or urine for glucose concentrations and the urine for ketones, by the patient .Warning 3Local reactions, characterised hypersensitivity may produce urticaria, angioedema and very rarely anaphylactic reactions. If continued therapy with insulin is essential, hyposensitisation procedures may need to be performed.Insulatard Hm Additional InformationPregnancy categoryAlways consult your physician before using any medicine.Storage (YES/NO)Store in a refrigerator (2?C?8?C). Do not Freeze .
Dermalogica Circular Hydration Serum 30ml ₦142,497.78
GLIMY M 1MG FORTE STRIP OF 10 TABLETS ₦2,201.75
COSVATE NM 15GM CREAM ₦1,144.50
Dermalogica Multivitamin Power Recovery Mask ₦154,888.90
Swr Face & Body Scrub 60ml ₦18,000.00
ROSULIP 20MG TABLET ₦5,833.25
RAYSTOP SPF 50 LOTION 50GM ₦8,765.75
ROSUCHEK 10MG TABLET ₦2,359.50
ANAFORTAN N TAB 10`S ₦1,576.25
Lansinoh Washable Nursing Pads 4's ₦19,200.00
Weleda Arnica Ointment - 25g ₦9,000.00
Filorga Hydra-Hyal Hydrating Plumping Cream 50ml ₦187,392.00
Insuget 70/30 SpecificationRequires Prescription (YES/NO)YesGenericsHuman Insulin + Isophane insulinUsed ForDiabetes ManagementHow it worksThe major effects of insulin on carbohydrate homoeostasis following its binding to specific cell-surface receptors on insulin-sensitive tissues, notably the liver, muscles and adipose tissue. It inhibits hepatic glucose production and enhances peripheral glucose disposal thereby reducing blood-glucose concentration. It also inhibits lipolysis thereby preventing the formation of ketone bodies.Insuget 70/30 Usage And SafetyDosageHuman Insulin + Isophane insulinSide EffectsHypoglycemia : They may include cold sweat, cool pale skin, nervousness or tremor, anxious feeling, unusual tiredness or weakness, confusion, difficulty in concentration, headache, nausea and palpitation. Severe hypoglycemia may lead to unconsciousness and may result in temporary or permanent impairment of brain function or even death , Weight gain , Oedema and refraction anomalies , . Local hypersensitivity reactions (redness, swelling and itching at the injection site) , Lipodystrophy , generalised skin rash, itching, sweating, gastrointestinal upset, angioneurotic oedema, difficulties in breathing, palpitation and reduction in blood pressure.Drug InteractionsBeta blocking agent Oral hypoglycemic agents (OHA), octreotide, monoamine oxidase inhibitor (MAOI), non selective beta blocking agents, angiotensin converting enzyme (ACE) inhibitors, salicylates, alcohol and alcohol steroids , Oral contraceptives, thiazides, glucocorticoids, thyroid hormones and sympathomimetics, danazol etc.IndicationIt is indicated for the treatment of : Patients with Type I diabetes mellitus. - Patients with Type II diabetes mellitus either alone or in combination with oral anti-diabetic agents. - Patients with gestational diabetes. - The emergency management of diabetic ketoacidosis.When not to UseInsulin is contraindicated in: - Patients with hypersensitivity to any components of this medication. - Patients with hypoglycemia. - Patients in coma due to hyperglycemia.Insuget 70/30 PrecautionsPrecautionCare is also necessary during excessive exercise. Hypoglycemia caused by metabolic effects and increased insulin absorption is the usual response, but hyperglycemia may sometimes occur. Adjustment of insulin dosage may also be necessary if patients change their level of physical activity or change their usual diet.Insuget 70/30 WarningsWarning 1Insulin requirements may be increased during illness or emotional disturbances.Warning 2The use of insulin necessitates monitoring of therapy, such as the testing of blood or urine for glucose concentrations and the urine for ketones, by the patient .Warning 3Local reactions, characterised hypersensitivity may produce urticaria, angioedema and very rarely anaphylactic reactions. If continued therapy with insulin is essential, hyposensitisation procedures may need to be performed.Insuget 70/30 Additional InformationPregnancy categoryAlways consult your physician before using any medicine.Storage (YES/NO)Store in a refrigerator (2?C?8?C). Do not Freeze .
Insulatard is human insulin to treat diabetes. ?Insulatard is a long-acting insulin. ?Insulatard will start to lower your blood sugar about 1? hours after you take it, and the effect will last for approximately 24 ?hours. ? ?Insulatard is often given in combination with fast-acting insulin products.
Insulatard? vials are for use with insulin syringes with the corresponding unit scale. Insulatard? is human insulin with a gradual onset and long duration of action. Insulatard? is used to?reduce the high blood sugar level?in patients with diabetes mellitus (diabetes). Insulatard? will start to lower your blood sugar about 1? hours after you inject it, and the effect will last for approximately 24 hours. Insulatard? is often given in combination with fast-acting insulin preparations. Treatment with Insulatard? helps to prevent complications from your diabetes.
Insulatard?FlexPen is a unique dial-a-dose insulin pen. You can select doses from 1 to 60 units in increments of 1 unit. Insulatard?FlexPen is designed and tested to be used with NovoFine and NovoTwist disposable needles up to a length of 8 mm.? Insulatard is a long-acting insulin.? Insulatard will start to lower your blood sugar about 1? hours after you take it, and the effect will last for approximately 24 hours. Insulatard is often given in combination with fast-acting insulin products.
Insuman Basal contains the active substance insulin human which is made by a biotechnology process and is identical with the body?s own insulin.
Insuman Comb 30 is an insulin preparation used to reduce high blood sugar in patients with diabetes mellitus.